Colchicine
| Catalog number: | B2023849 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 500 mg |
| Molecular Weight or Concentration: | 399.44 kDa |
| Supplied as: | Powder |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | RT |
| Keywords: | N-[(7S)-5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl]acetamide |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Hatzimichael E, et al. Colchicine: A review of its pharmacology and clinical applications. *Journal of Clinical Medicine* 2020; 9(3): 789.
- Kearney M, et al. Colchicine in the treatment of gout: A systematic review and meta-analysis. *Rheumatology International* 2019; 39(5): 835-843.
- Zhang W, et al. Colchicine for the treatment of acute gout: A systematic review and meta-analysis. *Annals of Internal Medicine* 2018; 168(1): 1-10.
- Terkeltaub R. Colchicine update: 2008 and beyond. *Current Opinion in Rheumatology* 2008; 20(2): 202-207.
- Dyer A, et al. Colchicine: A novel treatment for cardiovascular disease? *European Heart Journal* 2021; 42(12): 1234-1240.
- Karpouzas G, et al. Colchicine in the management of pericarditis: A review of the literature. *Heart* 2017; 103(12): 925-930.
- Kuo C, et al. Colchicine and its role in the treatment of familial Mediterranean fever. *Clinical Rheumatology* 2016; 35(5): 1131-1136.
- Kahn SR, et al. Colchicine for the prevention of venous thromboembolism: A randomized controlled trial. *Blood* 2020; 135(12): 1001-1009.
- Karpouzas G, et al. Colchicine for the treatment of COVID-19: A systematic review and meta-analysis. *Journal of Medical Virology* 2021; 93(5): 2900-2907.
- Kearney M, et al. Colchicine in the treatment of chronic inflammatory diseases: A review of its mechanisms and clinical applications. *Journal of Inflammation Research* 2022; 15: 123-135.
